Recent Articles from GlobeNewswire

New integration streamlines Medicare workflows while keeping client data centralized in AMS+

Physician-led partnership deepens access to behavioral healthcare through partnership with AR Psychiatric & Counseling Center Georgia and strengthens its growing behavioral health network across the nation

MCLEAN, Va., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading provider of AI-driven cybersecurity, IT security solutions, and managed services, today announced the successful closing of its acquisition of substantially all assets of Kustom Entertainment, Inc.’s (NASDAQ: KUST) (“Kustom”) legacy video solutions segment (the “Business”).

Proceeds to Address Creditor Obligations

LITTLE ROCK, Ark., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leader in artificial intelligence-driven advertising technology, will host a conference call on Tuesday, August 11, 2026, at 4:15 PM Eastern Time to discuss its financial results and provide a business update for the first quarter ended June 30, 2026.

PHOENIX, Ariz., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pathfinder announces the launch of its platform, providing families participating in the state’s Empowerment Scholarship Account (ESA) program with a simpler way to purchase approved educational supplies and services.

Original content series brings together fan culture, menu innovation and the unexpected

HOUSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) (“Sysco” or the “company”) today announced financial results for its 13-week fourth fiscal quarter and its fiscal year ended June 27, 2026.

Initiative helps global manufacturers turn operational data into greater capacity, stronger quality and measurable financial results

IRVING, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- XBP Global Holdings, Inc. ("XBP Global" or "the Company") (NASDAQ: XBP), a multinational technology and services company orchestrating mission-critical systems that enable hyper-automation and digital transformation, today announced it has been named a Major Player in the 2026 IDC MarketScape for Worldwide Mailroom Solutions and Services.

Transaction Highlights

LONDON and NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Aiviq, a leading global client data platform for the asset management industry, has been selected by Allspring Global Investments to establish a global, enterprise-grade Client Book of Record (CBOR) platform. The platform will help unify client assets, flows, and sales attribution across Allspring's distribution business, providing a single, reconciled view of client activity. The agreement marks a significant milestone for Aiviq North America, which launched in October 2025 and is building momentum across the North American markets.

FedRAMP®-Authorized Global Address Management and Identity Solutions Now Available to the Public Sector

Second Quarter 2026 Financial Highlights

Disclosure of Transactions in Own Shares – Period from July 27, 2026 to July 31, 2026

Partnership brings together Fiserv’s Commerce Hub with Mastercard’s advanced merchant services to help merchants innovate, expand, and improve payment performance across channels and markets

Achieved record total revenue, test volume and trailing twelve-month ASP

TORONTO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group” or “Altus”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, announced today that it has signed a definitive agreement to sell its Development Advisory business to an affiliate of Newmark Group, Inc. (“Newmark”) (NASDAQ: NMRK), a leading commercial real estate advisor and service provider to large institutional investors, global corporations and other owners and occupiers. The transaction, which is expected to close on September 1, 2026, includes Altus’ Development Advisory operations in North American and Asia Pacific.

Salt Lake City, UT, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in the following upcoming investor conferences:

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SHY Therapeutics (“SHY” or “the Company”), a clinical-stage biotechnology company developing small molecules that non-covalently target ATPases and GTPases and modulate their activity, today announced that the first patient has been dosed in Luca-1, the Company's first-in-human Phase 1 clinical trial evaluating SHY-ONC6, an investigational, novel and potentially first-in-class oral proteasome inhibitor for patients with advanced solid tumors. The Company expects initial Phase 1 data in 2027.

The companies supported Elemental Royalty’s completed dividend distribution, expanding shareholder choice while maintaining traditional payment options

Repeat deployment expands digital workforce, safety and jobsite operations through Veea’s intelligent edge platform

DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes”, “ASPI” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today released the following letter to shareholders from its Executive Chairman and Chief Executive Officer, Paul Mann.

Deliveries of body and chassis components expected to begin arriving in October, supporting Aptera’s plan to reach start of production

Chatelle Lynch, Carlos Mercuriali, and Bala Chandran join Vertex, advancing the company's vision for how the world's leading brands transact, comply, and grow

CHICAGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Portillo’s (NASDAQ: PTLO), the fast-casual restaurant concept known for serving Chicago-style favorites for more than 60 years, today announced the appointment of Kevin Kalicak as Chief Financial Officer and Treasurer, effective September 7, 2026.

CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Healis Therapeutics announced that it has opened an IND with the U.S. FDA for Tyemvers®, a new botulinum toxin type A product. The milestone enables Healis to initiate its U.S. clinical trial, enter clinical-stage research and development, and advance toward participation in the therapeutic botulinum toxin market.

Option exercise contract modification from the Office of Naval Research for the Intelligent Autonomous Systems for Seabed Warfare program advances Navy’s decision-making tech

Legal professionals, LexisNexis engineers, and AI collaborators like OpenAI and Amazon Web Services build side by side, solving workflow pain points with prototypes in hours and trusted products in weeks

BEIJING, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, today announced the official launch of Homeglow AI on the App Store and Google Play.

To mark World Breastfeeding Week, Medela announces the recipient of its research contribution and launches a month-long campaign highlighting evidence-based lactation care

Collaboration connects Arca’s legal AI agents with Arctera AI Converge, helping legal and compliance teams apply AI to governed communications, files and historical enterprise context

Educational dinner events help pre-retirees and retirees navigate taxes, market uncertainty and retirement planning.

New finance context graph combines organization-specific knowledge, human-approved business rules and deterministic execution, beginning with accounts payable

Combining leading in-house expertise with platform-enhancing investments to accelerate advances in engineering, innovation and manufacturing capabilities serving global medical device innovators

FRISCO, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Mission Critical Group (“MCG”), a leading provider of end-to-end electrical infrastructure solutions for mission critical facilities, including data centers, manufacturing plants, and energy infrastructure, today announced its acquisition of Anchor Automation, a provider of industrial automation, controls integration, and connected services.

Collaboration brings ExynAI and Nexys to UP Caeli Via's compact ARGOS UAS, expanding autonomous mapping opportunities across industrial, infrastructure, and inspection markets

GUANGZHOU, China, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Recently, seven journalists from leading media from APEC member economies visited Guangdong as part of the APEC China Year international media tour. As a key gateway for China's opening up in the Guangdong-Hong Kong-Macao Greater Bay Area and a strategic hub connecting the Asia-Pacific market, Nansha District, Guangzhou was a key stop on the media tour. The Nansha visit was jointly organized by the News & Information Center of Xinhua News Agency Guangdong Bureau and the Publicity Department of the CPC Nansha District Committee.

Bolt-on acquisition expected to contribute to Group revenue and net income in the first full quarter following completion

LOUISVILLE, Ky., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced today that it will release its financial results for the three months ended June 30, 2026 before the market open on Thursday, August 13, 2026. A conference call to review the results is scheduled for Thursday, August 13, 2026, at 9:00 am Eastern Time, which will include prepared remarks and materials from management followed by a live Q&A. The call will be hosted by Rick Mills, Chairman and Chief Executive Officer, Tamra Koshewa, Chief Financial Officer and George Sautter, Chief Strategy Officer.

NTAP Designation Expected to Support Medicare Patient Access, Treatment Center Economics and Commercial Adoption

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

WAKIX® Net Revenue Grew 30% Year over Year to $261.3 Million for Second Quarter 2026; Estimated Average Patients Increased 450 to 8,950; Reiterates 2026 WAKIX Net Revenue Guidance of $1.0 Billion to $1.04 Billion

First module of the rolling NDA for QTORIN™ rapamycin for microcystic lymphatic malformations submitted to FDA, with completion of the NDA submission on track for the second half of 2026

Dr. Graves will continue in his role until a successor is appointed

Supporting partners, communities, and governments in advancing equitable, climate resilient, and sustainable drinking water systems

TORONTO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (TSX:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today reported that monthly trading volume on Abaxx Exchange more than doubled in July 2026.

New agreement builds on commercialization and development of precision-fermented dairy proteins and enzymes while reinforcing Dyadic's diversified commercialization strategy

NORTH BETHESDA, Md., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ: XMTR), the global AI-native marketplace connecting buyers and suppliers of custom manufacturing, today announced its financial results for the second quarter ended June 30, 2026.

Strengthening the Software Layer of its Vertically Integrated AI Cloud Platform

-- U.S. launch of IMCIVREE® (setmelanotide) for acquired hypothalamic obesity (HO) starts strong with more than 400 patient start forms since FDA approval as of June 30, 2026 ---- Second quarter 2026 net product revenue from global sales of IMCIVREE of $71.3 million ---- Weekly injectable MC4R agonist RM-718 achieved mean BMI reduction of 11.6% in patients with acquired HO (n=7) after 16 weeks of treatment --

NEW HAVEN, Conn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on August 1, 2026, Invivyd granted ten newly hired non-executive employees options to purchase an aggregate of 277,500 shares of its common stock, each as a material inducement for each employee’s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan. 

ROLLING MEADOWS, Ill., Aug. 04, 2026 (GLOBE NEWSWIRE) -- RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and Dogwalkers, today announced financial results for the second quarter ended June 30, 2026.

Appoints Julien Perrier Chief Commercial Officer

Proceeds of $50.1 million will be used to support the Company’s advancement of CMP-002 for the treatment of SYNGAP1-related disorder

ST. LOUIS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global proactive wellness category, today reported results for the third fiscal quarter ended June 30, 2026.

Updated BEAM-302 Phase 1/2 Clinical Data Selected for Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026

OAK RIDGE, Tenn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- HYPERLINK "triso-x.com"TRISO-X, LLC ("TRISO-X" or the “Company”), a wholly-owned subsidiary of X-Energy, Inc. (Nasdaq: XE) (“X-energy”), today announced the acquisition of approximately 70 acres of land adjacent to its commercial nuclear fuel campus in Oak Ridge, Tennessee, to support the continued development of the Company’s fuel fabrication campus. The expansion brings the total site footprint to over approximately 180 acres, supporting ongoing construction of a world-class TRISO-X fuel campus that advances East Tennessee’s position at the center of American innovation in advanced nuclear fuels.

Key Appointment to Support Customer-Driven Commercialization Efforts

MALVERN, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced that the Board of Directors (the “Board”) has appointed Heather Getz as Chief Executive Officer and Director, effective today. 

– Quarterly Revenue of $163.4 million –

Lisata has filed suit against Kuva Labs Inc. and its subsidiary seeking, among other things, damages for the benefit of its stockholders

WATERTOWN, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced Peter Smith, Ph.D., Co-Founder and Chief Executive Officer of Remix, will present a corporate overview at the 46th Annual Canaccord Genuity Growth Conference on Tuesday, August 11, 2026, at 12:30 p.m. ET in Boston.

SINGAPORE, Aug. 04, 2026 (GLOBE NEWSWIRE) -- TOP Financial Group Limited (NASDAQ: TOP, “TOP” or the “Company”), a fast-growing online brokerage firm specializing in local and foreign equities, futures, and options products, today announced that its Board of Directors has approved a major strategic initiative to expand the use of artificial intelligence (AI) across its core financial business. Under this new technical mandate, the Company will develop and deploy advanced AI solutions designed to create scalable, technology-driven business lines while directly supporting and optimizing its core fintech operations.

FOSTER CITY, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA with a fireside chat at 1:00pm ET (link here).

BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces that its Chief Executive Officer, Ivor Elrifi has increased his holdings with the purchase of 667,000 of the Company’s common shares on NASDAQ at $1.00 per share, bringing his total holding to 4,472,261 common shares.

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced financial results for the second quarter ended June 30, 2026. Financial results in this release, including all comparisons to prior year periods, reflect continuing operations only. The results of the divested Passenger business have been reclassified as discontinued operations in all periods.

Black Pearl Data Center Delivery Accelerated

THE WOODLANDS, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced financial results for the second quarter and the six months ended June 30, 2026.

Data from the Phase 2a monotherapy trial of OD-001 accepted for oral presentation at United European Gastroenterology Week in October

DNTH312 is an internally developed bifunctional fusion protein targeting potent inhibition of active C1s (aC1s) and BAFF/APRIL, two validated pathways with complementary disease modifying mechanisms

WATERLOO, Ontario and ATLANTA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report its second quarter fiscal 2027 financial results after market close on Thursday, September 10, 2026.